Dr Ashish M. Kamat is a Professor and Attending Surgeon in the Department of Urology/Division of Surgery.  He is also the Director of the Urologic Oncology Fellowship Program. 

Dr Kamat is an internationally recognized expert in urologic oncology. He has a special interest in cancers of the bladder and prostate with an emphasis on organ sparing therapies, minimally invasive techniques (e.g. robotic surgery) and orthotopic bladder substitution (neobladder). While he is a busy clinically active surgeon, he maintains an active research portfolio in order to improve the care of patients. In the clinical arena, in concert with efforts to develop novel therapies, Dr Kamat’s efforts are directed towards identifying predictors of response to therapy - especially immunotherapy - as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer using an approach which encompasses novel use of existing agents, the identification or novel targets and therapies, or a combination of these strategies.  

Dr Kamat has authored numerous editorials close to 180 publications in prestigious peer reviewed journals, serves on the editorial board of Expert Reviews in Anticancer and F1000 Reviews and Urologic Oncology. His basic, translational and clinical research is funded by peer-reviewed awards including from the National Cancer Institute. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE, which is the only one of its kinds in the country. He has served on the NCI Bladder Cancer task force, on Grant Review Committees such as NIH-RO1 study sections as well as for international societies (Dutch Cancer Society and NIH - Singapore).

Dr Kamat is listed in 'Who's Who in Medicine' and ‘Best Doctors in America’ and has received the 'Compassionate Doctor Award'. He is active in many cancer support groups for patients such as the MD Anderson Bladder Support Group (for which he serves as Medical Director) and the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN).

Dr Kamat is an active member of the urologic community, and a graduate of the AUA Leadership Program. He serves on the Board of Directors for the SCS of the AUA and is The State Representative (Texas) for Urology.